Microsoft stock just suffered its biggest single day drop since 2020. Meanwhile, Meta stock popped by 10%.

HubSpot (HUBS) has suffered a 65% stock decline amid AI disruption fears, despite maintaining strong growth and margins. HUBS trades at all-time low multiples (~4.3x forward revenue), with the market heavily discounting its growth profile and pricing in significant AI risk. Management remains confident in long-term growth, positioning AI as a complementary tailwind and aiming to deliver value beyond LLM capabilities.

Alcoa's (NYSE:AA) latest earnings report offered a clear view of how significantly the company's fundamentals have elevated over the past year. In its most recent quarterly earnings, the aluminum manufacturer reported revenues of approximately $3.4 billion, showcasing a robust sequential increase fueled by elevated aluminum and alumina prices along with enhanced shipment volumes.

The pick is in! Pres. Trump announced his plans to nominate Kevin Warsh for the Federal Reserve Chair.

Moderna's Chief Medical Officer Jacqueline Miller, who led the development of the company's mRNA-based COVID-19 vaccine Spikevax, will step down effective March 2, the vaccine maker said on Friday.

ADM's Q4 results are expected to reflect EPS declining as Ag Services, Oilseeds and Carbohydrates face margin pressure despite Nutrition stability.

Church & Dwight (CHD) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.77 per share a year ago.

Colgate-Palmolive (CL) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.91 per share a year ago.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 30, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) ("CoreWeave" or the "Company") on behalf of investors who purchased or otherwise acquired CoreWeave securities during the period from March 28, 2025 through December 15, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased CoreWeave securities during the Class Period may, no later than March 13, 2026, seek to be appointed as a lead plaintiff representative of the class.

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina's NGS ecosystem, DRAGEN software, and Illumina Connected Multiomics to rapidly transform insights into discoveries SAN DIEGO, Jan. 30, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The highly complementary proteomics capabilities expand Illumina's multiomics portfolio, strengthening customer access to proteomic insights at scale to help drive faster drug discovery and positively impact health care.

Altria (MO) is rated strong sell due to deteriorating fundamentals and an overvalued stock price. MO's premium Marlboro volumes crashed 12.6% in Q4, with overall cigarette volumes declining faster than the industry. Smokeless segment growth is insufficient to offset steep declines in the core cigarette business, with on! losing market share in Q4.

Microsoft's stock saw its biggest daily decline since 2020 on Thursday, falling 10%. The stock is up 0.5% premarket on Friday.

Pfizer PFE is set to report its fourth-quarter and full-year 2025 earnings on Feb. 3, before market open. The Zacks Consensus Estimate for sales and earnings for the fourth quarter is pegged at $16.93 billion and 57 cents per share, respectively.

Morgan Stanley's wealth and asset management arms now drive 54% of revenues, powered by sticky assets and recurring fees.

CLX's Q2 results may reflect revenue and EPS declines as inflation-driven cost pressures and ERP disruptions weigh on margins despite brand strength.

TSN's Q1 results are likely to show strong protein demand and operational gains, but higher costs could pressure profits.

A growing corner of Wall Street views uranium as the next gold and silver trade, meaning investors should buy some nuclear fuel stocks now for huge upside in 2026 and beyond.

LyondellBasell (LYB) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of $0.18. This compares to earnings of $0.75 per share a year ago.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bath & Body Works To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Bath & Body Works between June 4, 2024 and November 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 30, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bath …

Honeywell Q4 Earnings Review: Margin Expansion Is Just Beginning